Empowering the future of biotech and pharma research through antibody-cell affinity and avidity measurements

Vysens develops and provides instruments for biomolecular interaction analysis, specifically for clinical cancer and autoimmune research. More than thirty years of experience and knowledge in the field of antibody-antigen interactions, fluidics and SPR, together with a unique novel technology, have been combined into the CellVysion. 

Vysens’ CellVysion is the only platform that directly measures functional antibody-cell avidity in real time, live and label-free. This easy-to-use instrument helps researchers to characterize antibodies, cells, and other biomolecules in real-time, aiding in the development of diagnostics and therapeutics.

Find out how our technology works.

CellVysion